BRIEF published on 04/02/2024 at 12:05, 7 months 19 days ago CannapharmaRx Successfully Repays Convertible Notes to Strengthen Position Convertible Notes Debt Repayment Shareholder Interests CannapharmaRx Cannabis Production
PRESS RELEASE published on 04/02/2024 at 12:00, 7 months 19 days ago CannapharmaRx Pays Off Convertible Notes CannapharmaRx, Inc. announces the extinguishment of convertible notes to avoid stock dilution and strengthen the company. CEO Dean Medwid discusses the positive impact on future growth and valuation Convertible Notes Future Growth CannapharmaRx Stock Dilution CEO Dean Medwid
PRESS RELEASE published on 04/19/2023 at 14:30, 1 year 7 months ago CannaPharmaRx Signs Agreement with Nasha Genetics
PRESS RELEASE published on 03/30/2023 at 15:00, 1 year 7 months ago CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis
PRESS RELEASE published on 03/21/2023 at 13:30, 1 year 8 months ago CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website
PRESS RELEASE published on 02/21/2023 at 15:00, 1 year 8 months ago CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company
PRESS RELEASE published on 02/01/2023 at 14:30, 1 year 9 months ago CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock
PRESS RELEASE published on 01/30/2023 at 15:00, 1 year 9 months ago CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023
PRESS RELEASE published on 01/11/2023 at 15:00, 1 year 10 months ago CannaPharmaRx Receives Canada Revenue Agency (CRA) License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected
Published on 11/21/2024 at 14:15, 16 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 31 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 31 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 31 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 15 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 16 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 56 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 33 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 11 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 46 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 46 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo